Owens & Minor ROE 2006-2018 | OMI

Current and historical return on equity (ROE) values for Owens & Minor (OMI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Owens & Minor ROE for the three months ending December 31, 2018 was 8.99%.
Owens & Minor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $-0.44B $0.52B -55.83%
2018-09-30 $-0.15B $0.79B -16.87%
2018-06-30 $-0.14B $0.80B -14.69%
2018-03-31 $0.06B $1.02B 6.15%
2017-12-31 $0.07B $1.02B 7.33%
2017-09-30 $0.08B $1.00B 7.84%
2017-06-30 $0.10B $0.99B 9.82%
2017-03-31 $0.10B $0.97B 10.53%
2016-12-31 $0.11B $0.96B 10.94%
2016-09-30 $0.11B $0.99B 11.35%
2016-06-30 $0.11B $1.00B 11.16%
2016-03-31 $0.11B $1.01B 10.91%
2015-12-31 $0.10B $0.99B 10.50%
2015-09-30 $0.09B $0.99B 8.67%
2015-06-30 $0.06B $0.98B 6.49%
2015-03-31 $0.06B $0.97B 6.00%
2014-12-31 $0.07B $0.99B 6.50%
2014-09-30 $0.08B $1.01B 7.81%
2014-06-30 $0.10B $1.03B 9.87%
2014-03-31 $0.11B $1.03B 10.85%
2013-12-31 $0.11B $1.03B 11.10%
2013-09-30 $0.11B $1.01B 10.94%
2013-06-30 $0.10B $0.99B 10.66%
2013-03-31 $0.11B $0.98B 10.88%
2012-12-31 $0.11B $0.97B 11.31%
2012-09-30 $0.11B $0.96B 11.37%
2012-06-30 $0.12B $0.95B 12.50%
2012-03-31 $0.12B $0.94B 12.58%
2011-12-31 $0.11B $0.92B 12.66%
2011-09-30 $0.11B $0.91B 12.65%
2011-06-30 $0.11B $0.90B 12.67%
2011-03-31 $0.11B $0.88B 12.97%
2010-12-31 $0.11B $0.86B 13.32%
2010-09-30 $0.12B $0.84B 15.05%
2010-06-30 $0.12B $0.82B 15.88%
2010-03-31 $0.12B $0.79B 15.75%
2009-12-31 $0.11B $0.77B 14.35%
2009-09-30 $0.09B $0.75B 12.93%
2009-06-30 $0.08B $0.71B 11.95%
2009-03-31 $0.08B $0.70B 12.19%
2008-12-31 $0.09B $0.69B 13.97%
2008-09-30 $0.10B $0.68B 14.69%
2008-06-30 $0.09B $0.66B 14.55%
2008-03-31 $0.09B $0.64B 14.07%
2007-12-31 $0.07B $0.61B 12.33%
2007-09-30 $0.06B $0.59B 10.05%
2007-06-30 $0.05B $0.57B 9.01%
2007-03-31 $0.04B $0.55B 7.71%
2006-12-31 $0.05B $0.55B 8.92%
2006-09-30 $0.06B $0.55B 10.76%
2006-06-30 $0.06B $0.53B 11.57%
2006-03-31 $0.07B $0.53B 13.02%
2005-12-31 $0.07B $0.51B 13.17%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.214B $9.839B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Boston Scientific (BSX) United States $48.570B 23.60
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00